Publications by authors named "Mengran Lang"

Claim this Profile
A
A novel evaluation benchmark for medical LLMs illuminating safety and effectiveness in clinical domains.
Shirui Wang, Zhihui Tang, Huaxia Yang, Qiuhong Gong, Tiantian Gu, Mengran Lang

NPJ Digit Med· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Current advance in comprehensive management of hilar cholangiocarcinoma and navigation in surgery: non-systematic reviews.
Man Luo, Jiapeng Yang, Kai Zhang, Ji Sun, Zhiyu Lu, Mengran Lang

Int J Surg· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lenvatinib, sintilimab combined interventional treatment bevacizumab, sintilimab combined interventional treatment for intermediate-advanced unresectable hepatocellular carcinoma.
Ru-Yu Han, Lei-Juan Gan, Meng-Ran Lang, Shao-Hua Ren, Dong-Ming Liu

World J Gastroenterol· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Benefit of Conversion Therapy in Patients with Unresectable Hepatocellular Carcinoma: A Propensity Score-Matched Study.
Ruyu Han, Leijuan Gan, Liyu Sun, Mengran Lang, Xindi Tian

J Hepatocell Carcinoma· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Retrospective Study on Predicting Recurrence of Intermediate-Stage Hepatocellular Carcinoma After Radical Therapy.
Ruyu Han, Leijuan Gan, Mengran Lang, Guangtao Li, Lu Chen

J Hepatocell Carcinoma· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Laparoscopic Anatomical Liver Resection of Segment VIII by Using ICG Fluorescence Positive Staining Under the Guidance of Laparoscopic Ultrasonography.
Ji Sun, Zhi-Yu Lu, Jian-Xin Zhai, Meng-Ran Lang, Hong-Guang Wang

Ann Surg Oncol· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lenvatinib plus sintilimab with or without transarterial chemoembolization for intermediate or advanced stage hepatocellular carcinoma: a propensity score-matching cohort study.
Mengran Lang, Leijuan Gan, Shaohua Ren, Ruyu Han, Xiaochen Ma

Am J Cancer Res· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Retrospective Analysis of Conversion Therapy with Lenvatinib, Sintilimab, and Arterially-Directed Therapy in Patients with Initially Unresectable Hepatocellular Carcinoma.
Leijuan Gan, Mengran Lang, Xindi Tian, Shaohua Ren, Guangtao Li

J Hepatocell Carcinoma· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Ectopic hepatocellular carcinoma of the right adrenal gland: a case description.
Leijuan Gan, Shaohua Ren, Mengran Lang, Feng Fang, Lu Chen

Quant Imaging Med Surg· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictive Value of Preoperative Serum AFP, CEA, and CA19-9 Levels in Patients with Single Small Hepatocellular Carcinoma: Retrospective Study.
Leijuan Gan, Shaohua Ren, Mengran Lang, Guangtao Li, Feng Fang

J Hepatocell Carcinoma· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of sequential therapy with sorafenib and regorafenib for advanced hepatocellular carcinoma: a two-center study in China.
Shao-Hua Ren, Zi-Lin Cui, Meng-Ran Lang, Qiang Li, Wei Zhang

J Gastrointest Oncol· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The past, present and future of conversion therapy for liver cancer.
Tianqiang Song, Mengran Lang, Shaohua Ren, Leijuan Gan, Wei Lu

Am J Cancer Res· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis